Suppr超能文献

托拉洛尔的降压作用。

Antihypertensive effects of tolamolol.

作者信息

Vlachakis N D, Mendlowitz M, Krakoff L R

出版信息

Clin Pharmacol Ther. 1977 Jan;21(1):9-15. doi: 10.1002/cpt19772119.

Abstract

The antihypertensive and renin-lowering efficacy and side effects of tolamolol, a beta adrenergic blocking drug with cardioselectivity, were examined in 10 patients with mild essential hypertension while on regular diet. Tolamol, at a dose of 300 to 900 mg per day, given over a period of 2 to 4 wk significantly decreased systolic and diastolic blood pressures in both the recumbent and standing positions. Normal blood pressure (140/90 mm Hg or less) was attained in 8 subjects. Mean heart rate and ambulatory midday plasma renin activity (PRA) decreased significantly; however, there was no significant correlation between blood pressure decrease and either the pretreatment PRA or decrease in PRA. Body weight did not change significantly. No adverse side effects were detected and no changes in the liver or renal function or in the blood count were observed. It is concluded that tolamolol is effective in lowering blood pressure and PRA in patients with hypertension.

摘要

在10例轻度原发性高血压患者日常饮食期间,对具有心脏选择性的β肾上腺素能阻断药托拉洛尔的降压和降肾素疗效及副作用进行了研究。托拉洛尔剂量为每日300至900毫克,给药2至4周,显著降低了卧位和立位的收缩压和舒张压。8名受试者血压恢复正常(140/90毫米汞柱或更低)。平均心率和动态午间血浆肾素活性(PRA)显著降低;然而,血压下降与治疗前PRA或PRA降低之间均无显著相关性。体重无显著变化。未检测到不良副作用,未观察到肝功能、肾功能或血细胞计数有变化。结论是托拉洛尔对高血压患者降低血压和PRA有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验